These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 3125081

  • 1. Pathogenetic heterogeneity in retinal capillary basement membrane thickening in the diabetic BB-rat.
    Chakrabarti S, Sima AA.
    Diabetologia; 1987 Dec; 30(12):966-8. PubMed ID: 3125081
    [Abstract] [Full Text] [Related]

  • 2. Effect of aldose reductase inhibition and insulin treatment on retinal capillary basement membrane thickening in BB rats.
    Chakrabarti S, Sima AA.
    Diabetes; 1989 Sep; 38(9):1181-6. PubMed ID: 2504638
    [Abstract] [Full Text] [Related]

  • 3. The effect of acarbose on diabetes- and age-related basement membrane thickening in retinal capillaries of the BB/W-rat.
    Chakrabarti S, Cherian PV, Sima AA.
    Diabetes Res Clin Pract; 1993 May; 20(2):123-8. PubMed ID: 8375264
    [Abstract] [Full Text] [Related]

  • 4. Prevention of diabetes-related retinal microangiopathy with aldose reductase inhibitors.
    Robison WG.
    Adv Exp Med Biol; 1988 May; 246():365-72. PubMed ID: 3150650
    [Abstract] [Full Text] [Related]

  • 5. The effect of myo-inositol treatment on basement membrane thickening in the BB/W-rat retina.
    Chakrabarti S, Sima AA.
    Diabetes Res Clin Pract; 1992 Apr; 16(1):13-7. PubMed ID: 1576927
    [Abstract] [Full Text] [Related]

  • 6. Capillary basement membrane in retina, kidney, and muscle of diabetic dogs and galactosemic dogs and its response to 5 years aldose reductase inhibition.
    Engerman RL, Kern TS, Garment MB.
    J Diabetes Complications; 1993 Apr; 7(4):241-5. PubMed ID: 8219367
    [Abstract] [Full Text] [Related]

  • 7. Pancreatic islet allograft prevents basement membrane thickening in the diabetic rat retina.
    Sima AA, Chakrabarti S, Tze WJ, Tai J.
    Diabetologia; 1988 Mar; 31(3):175-81. PubMed ID: 3131171
    [Abstract] [Full Text] [Related]

  • 8. Tight glycemic control regulates fibronectin expression and basement membrane thickening in retinal and glomerular capillaries of diabetic rats.
    Cherian S, Roy S, Pinheiro A, Roy S.
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):943-9. PubMed ID: 18775856
    [Abstract] [Full Text] [Related]

  • 9. Retinal capillary dilation: early diabetic-like retinopathy in the galactose-fed rat model.
    Glover JP, Jacot JL, Basso MD, Hohman TC, Robison WG.
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):167-72. PubMed ID: 10803427
    [Abstract] [Full Text] [Related]

  • 10. Effects of an aldose reductase inhibitor, SNK-860, on the histopathological changes of retinal tissues in a streptozotocin-induced diabetic rat model.
    Akita M, Mizuno K, Matsubara A, Nakano K, Kurono M.
    Acta Med Okayama; 1993 Oct; 47(5):299-304. PubMed ID: 8273453
    [Abstract] [Full Text] [Related]

  • 11. Intervention with the aldose reductase inhibitor, tolrestat, in renal and retinal lesions of streptozotocin-diabetic rats.
    McCaleb ML, McKean ML, Hohman TC, Laver N, Robison WG.
    Diabetologia; 1991 Oct; 34(10):695-701. PubMed ID: 1959701
    [Abstract] [Full Text] [Related]

  • 12. Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor.
    Robison WG, Tillis TN, Laver N, Kinoshita JH.
    Exp Eye Res; 1990 Apr; 50(4):355-66. PubMed ID: 2110907
    [Abstract] [Full Text] [Related]

  • 13. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats.
    Robison WG, Jacot JL, Glover JP, Basso MD, Hohman TC.
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1933-41. PubMed ID: 9727416
    [Abstract] [Full Text] [Related]

  • 14. Glomerular basement membrane thickening in streptozotocin diabetic rats despite treatment with an aldose reductase inhibitor.
    Osterby R, Gundersen HJ.
    J Diabet Complications; 1989 Sep; 3(3):149-53. PubMed ID: 2528558
    [Abstract] [Full Text] [Related]

  • 15. Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats.
    Kojima K, Matsubara H, Harada T, Mizuno K, Suzuki M, Hotta N, Kakuta H, Sakamoto N.
    Jpn J Ophthalmol; 1985 Sep; 29(1):99-109. PubMed ID: 3159927
    [Abstract] [Full Text] [Related]

  • 16. The effect of aldose reductase inhibition with ponalrestat on the width of the capillary basement membrane in diabetes mellitus.
    Ramirez LC, Arauz C, Pruneda L, Hammon K, Rosenstock J, Raskin P.
    Diabetes Res Clin Pract; 1991 Feb; 11(2):73-80. PubMed ID: 1902410
    [Abstract] [Full Text] [Related]

  • 17. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.
    Das A, Frank RN, Zhang NL, Samadani E.
    Exp Eye Res; 1990 Mar; 50(3):269-80. PubMed ID: 2108050
    [Abstract] [Full Text] [Related]

  • 18. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
    Robison WG, Nagata M, Laver N, Hohman TC, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395
    [Abstract] [Full Text] [Related]

  • 19. Aldose reductase, diabetes, and thickening of the retinal inner limiting membrane.
    Nagata M, Robison WG.
    Invest Ophthalmol Vis Sci; 1987 Nov; 28(11):1867-9. PubMed ID: 3117719
    [Abstract] [Full Text] [Related]

  • 20. Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor.
    Robison WG, Kador PF, Kinoshita JH.
    Science; 1983 Sep 16; 221(4616):1177-9. PubMed ID: 6612330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.